About Depisteo
Depisteo is a company based in Atlanta (United States) founded in 2007. It operates as a B2B. Depisteo offers products and services including VT1 4K Vision Screener and Spirolyser Q13 Spirometer.
- Headquarter Atlanta, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website depisteo.com
- Social X Facebook
Products & Services of Depisteo
Depisteo offers a comprehensive portfolio of products and services, including VT1 4K Vision Screener and Spirolyser Q13 Spirometer.
Screens visual disorders in children and adults quickly and efficiently.
Measures lung capacity safely without contact for health assessments.
Web traffic of Depisteo
The website of Depisteo (depisteo.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▼ 17.4% vs previous month
Websites whose visitors overlap most with Depisteo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| galendata.com | 100% | – | – | View details |
Similar companies to Depisteo
10 companies that operate in the same segment as Depisteo (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Depisteo
Depisteo was founded in 2007.
Depisteo is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Depisteo develops innovative medical screening devices that efficiently detect visual disorders and measure respiratory capacity for all ages. These user-friendly tools, like the VT1 platform, improve workflows with customizable interfaces and quick testing. Based in Atlanta, Georgia, USA, the company focuses on enhancing medical equipment technology since 2007, serving healthcare professionals through direct sales and support.
Depisteo offers VT1 4K Vision Screener and Spirolyser Q13 Spirometer.